Corbus Pharmaceuticals Holdings's top three insider shareholders as of June 06, 2026 are Asset Management, Lp Cormorant (TenPercentOwner, 2.38Mn shares), Asset Management, Lp Cormorant (TenPercentOwner, 2.34Mn shares), Yuval Cohen (Chief Executive Officer, 174.32K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Avery W Catlin | - | 4,350 | 0 | 03 Jun, 2024 |
| Alan F Holmer | - | 10,629 | 0 | 02 Jun, 2025 |
| Sean F. Moran | Chief Financial Officer | 96,694 | 0 | 18 Feb, 2026 |
| Asset Management, Lp Cormorant | - | 0 | 2,375,000 | 24 Sep, 2024 |
| Yuval Cohen | Chief Executive Officer | 174,316 | 0 | 18 Feb, 2026 |
| Winston Kung | - | 10,366 | 0 | 02 Jun, 2025 |
| Craig Stuart Millian | Chief Operating Officer | 27,000 | 0 | 12 Aug, 2022 |
| Peter Salzmann | - | 2,783 | 0 | 03 Jun, 2024 |
| Dominic Smethurst | Chief Medical Officer | 89,790 | 0 | 04 Mar, 2026 |
| Anne Altmeyer | - | 6,191 | 0 | 21 Oct, 2025 |
| Yong Ben | - | 7,583 | 0 | 02 Jun, 2025 |
| Ian Hodgson | Chief Operating Officer | 51,080 | 0 | 18 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Mar, 2026 | Dominic Smethurst | Common Stock, par value $0.0001 per share | D | 6,097 | $8.30 | 89,790 | D | S |
| 02 Mar, 2026 | Dominic Smethurst | Common Stock, par value $0.0001 per share | D | 6,097 | $8.30 | 89,790 | D | S |
| 13 Feb, 2026 | Sean F. Moran | Common Stock, par value $0.0001 per share | D | 4,701 | $7.78 | 96,694 | D | S |
| 13 Feb, 2026 | Yuval Cohen | Common Stock, par value $0.0001 per share | D | 13,871 | $7.78 | 174,316 | D | S |
| 17 Feb, 2026 | Ian Hodgson | Common Stock, par value $0.0001 per share | D | 847 | $7.38 | 51,080 | D | S |
| 13 Feb, 2026 | Sean F. Moran | Common Stock, par value $0.0001 per share | D | 4,701 | $7.78 | 96,694 | D | S |
| 17 Feb, 2026 | Ian Hodgson | Common Stock, par value $0.0001 per share | D | 847 | $7.38 | 51,080 | D | S |
| 03 Feb, 2026 | Ian Hodgson | Common Stock, par value $0.0001 per share | D | 2,415 | $8.09 | 51,927 | D | S |
| 03 Feb, 2026 | Ian Hodgson | Common Stock, par value $0.0001 per share | D | 2,415 | $8.09 | 51,927 | D | S |
| 03 Feb, 2026 | Dominic Smethurst | Common Stock, par value $0.0001 per share | D | 3,285 | $8.09 | 95,887 | D | S |
| 03 Feb, 2026 | Dominic Smethurst | Common Stock, par value $0.0001 per share | D | 3,285 | $8.09 | 95,887 | D | S |
| 14 Jan, 2026 | Sean F. Moran | Common Stock, par value $0.0001 per share | A | 28,082 | $0.00 | 101,395 | D | A |
| 14 Jan, 2026 | Ian Hodgson | Common Stock, par value $0.0001 per share | A | 28,365 | $0.00 | 54,342 | D | A |
| 14 Jan, 2026 | Ian Hodgson | Common Stock, par value $0.0001 per share | A | 28,365 | $0.00 | 54,342 | D | A |
| 14 Jan, 2026 | Sean F. Moran | Common Stock, par value $0.0001 per share | A | 28,082 | $0.00 | 101,395 | D | A |
| 14 Jan, 2026 | Dominic Smethurst | Common Stock, par value $0.0001 per share | A | 28,365 | $0.00 | 99,172 | D | A |
| 14 Jan, 2026 | Yuval Cohen | Common Stock, par value $0.0001 per share | A | 50,000 | $0.00 | 188,187 | D | A |
| 14 Jan, 2026 | Dominic Smethurst | Common Stock, par value $0.0001 per share | A | 28,365 | $0.00 | 99,172 | D | A |
| 14 Jan, 2026 | Dominic Smethurst | Stock options (right to buy) | A | 85,095 | $0.00 | 85,095 | D | A |
| 14 Jan, 2026 | Ian Hodgson | Stock options (right to buy) | A | 85,095 | $0.00 | 85,095 | D | A |